Related references
Note: Only part of the references are listed.Targeting intrinsically disordered proteins at the edge of chaos
Hao Ruan et al.
DRUG DISCOVERY TODAY (2019)
Structural Basis of Small Molecule Targetability of Monomeric Tau Protein
Robert Kiss et al.
ACS CHEMICAL NEUROSCIENCE (2018)
CI-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation -Engendered Toxicity
Moran Frenkel-Pinter et al.
NEURODEGENERATIVE DISEASES (2017)
Mind the Metal: A Fragment Library-Derived Zinc Impurity Binds the E2 Ubiquitin-Conjugating Enzyme Ube2T and Induces Structural Rearrangements
Francesca E. Morreale et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2015)
Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
Marcus Pickhardt et al.
CURRENT ALZHEIMER RESEARCH (2015)
Intrinsically disordered proteins in cellular signalling and regulation
Peter E. Wright et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Demystifying fluorine chemical shifts: electronic structure calculations address origins of seemingly anomalous 19F-NMR spectra of fluorohistidine isomers and analogues
Chandana Kasireddy et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2015)
Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups
Yoshiyuki Soeda et al.
NATURE COMMUNICATIONS (2015)
Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation
Elias Akoury et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
Alex Crowe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Fragment-based drug discovery using NMR spectroscopy
Mary J. Harner et al.
JOURNAL OF BIOMOLECULAR NMR (2013)
Compound Aggregation in Drug Discovery: Implementing a Practical NMR Assay for Medicinal Chemists
Steven R. LaPlante et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
Bruno Bulic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Intrinsically disordered proteins: regulation and disease
M. Madan Babu et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2011)
Microtubule-associated Protein 1B (MAP1B) Is Required for Dendritic Spine Development and Synaptic Maturation
Elena Tortosa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Intrinsically disordered proteins are potential drug targets
Steven J. Metallo
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
Alex Crowe et al.
BIOCHEMISTRY (2009)
The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments
Sadasivam Jeganathan et al.
BIOCHEMISTRY (2008)
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of τ aggregation and toxicity in vitro and in cells
Marcus Pickhardt et al.
BIOCHEMISTRY (2007)
Rhodanine-based tau aggregation inhibitors in cell models of tauopathy
Bruno Bulic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
SOFAST-HMQC experiments for recording two-dimensional heteronuclear correlation spectra of proteins within a few seconds
P Schanda et al.
JOURNAL OF BIOMOLECULAR NMR (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tau aggregation is driven by a transition from random coil to beta sheet structure
M von Bergen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Measuring ligand-protein binding using NMR diffusion experiments
LH Lucas et al.
CONCEPTS IN MAGNETIC RESONANCE PART A (2004)
Surface plasmon resonance measurement of pH-induced responses of immobilized biomolecules: conformational change or electrostatic interaction effects?
S Paynter et al.
ANALYTICAL BIOCHEMISTRY (2002)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure
M von Bergen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Using receptor conformational change to detect low molecular weight analytes by surface plasmon resonance
JE Gestwicki et al.
ANALYTICAL CHEMISTRY (2001)
Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water
C Dalvit et al.
JOURNAL OF BIOMOLECULAR NMR (2000)
Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure
M von Bergen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
